Observational Study of How Patients Take Eye Drops

Robin, Alan L., M.D.220 enrolled

Overview

This study is interested in monitoring how patients take eye drops, both through video-recordings and adherence monitoring, as well as their perceptions about their eye medications; including the dosing schedules, instillation techniques and effect on their disease.

Study Type

OBSERVATIONAL

Enrollment

220

Conditions

Glaucoma

Interventions

MEMS capDEVICE

The Medication Event Monitoring System will be used to assess the level of subject adherence to recommended topical eye drop therapy.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * \>18 year old * currently taking 1 or more hypotensive topical eye drops takes drops in the right eye for more than 6 months expect to continue drop use for the next 3 months * subjects instill their own eye drops * subject is able to take HVF tests * subject will expect to complete the 3 months enrollment period Exclusion Criteria: * unable/unwilling to instill own medications * eye drops are discontinued * unable to take HVF test * unable to complete follow-up * investigators discontinue subject for safety reasons * not using drops in left eye

Locations (1)

Glaucoma Specialists

Baltimore, Maryland, United States

RECRUITING

Outcomes

Primary Outcomes

Medication adherence measured by MEMS caps

Time frame: 3 months

Eye drop technique measured by video evaluation

Time frame: 1 time observation

Secondary Outcomes

Medication adherence measured by self-report

Time frame: 3 months

Severity of VF damage

Time frame: 1 test date

Intraocular pressure readings

Time frame: 3 months

Central Contacts

Jennifer L Stone, OD

CONTACT

410 377 2422 jstone@glacuomaexpert.com

Colleen K Protzko

CONTACT

4103772422 cprotzko@glaucomaexpert.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.